These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31400633)

  • 1. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
    Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
    Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coevolution of brain structures in amnestic mild cognitive impairment.
    Carmichael O; McLaren DG; Tommet D; Mungas D; Jones RN;
    Neuroimage; 2013 Feb; 66():449-56. PubMed ID: 23103689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
    Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
    Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.
    Wang X; Huang K; Yang F; Chen D; Cai S; Huang L
    Behav Brain Res; 2021 Jul; 410():113330. PubMed ID: 33940051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.
    Eskildsen SF; Coupé P; García-Lorenzo D; Fonov V; Pruessner JC; Collins DL;
    Neuroimage; 2013 Jan; 65():511-21. PubMed ID: 23036450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.
    Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT;
    Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network.
    Daianu M; Jahanshad N; Nir TM; Jack CR; Weiner MW; Bernstein MA; Thompson PM;
    Hum Brain Mapp; 2015 Aug; 36(8):3087-103. PubMed ID: 26037224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
    Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
    Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data.
    Cho Y; Seong JK; Jeong Y; Shin SY;
    Neuroimage; 2012 Feb; 59(3):2217-30. PubMed ID: 22008371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal structural covariance network revealing atrophy progression in Alzheimer's disease continuum.
    Qing Z; Chen F; Lu J; Lv P; Li W; Liang X; Wang M; Wang Z; Zhang X; Zhang B;
    Hum Brain Mapp; 2021 Aug; 42(12):3950-3962. PubMed ID: 33978292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tau accumulation and atrophy in mild cognitive impairment: a longitudinal study.
    Xu G; Zheng S; Zhu Z; Yu X; Jiang J; Jiang J; Chu Z;
    Ann Nucl Med; 2020 Nov; 34(11):815-823. PubMed ID: 32785820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
    Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
    Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
    Nho K; Risacher SL; Crane PK; DeCarli C; Glymour MM; Habeck C; Kim S; Lee GJ; Mormino E; Mukherjee S; Shen L; West JD; Saykin AJ;
    Brain Imaging Behav; 2012 Dec; 6(4):551-67. PubMed ID: 23070747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.